UniSuper Management Pty Ltd Acquires 2,616 Shares of HCA Healthcare, Inc. (NYSE:HCA)

UniSuper Management Pty Ltd increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 59,310 shares of the company's stock after buying an additional 2,616 shares during the period. UniSuper Management Pty Ltd's holdings in HCA Healthcare were worth $17,802,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of HCA. Whipplewood Advisors LLC bought a new position in HCA Healthcare during the fourth quarter worth about $31,000. Tidemark LLC acquired a new position in HCA Healthcare during the fourth quarter valued at approximately $36,000. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare during the third quarter worth $39,000. Activest Wealth Management increased its position in shares of HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after buying an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. increased its holdings in shares of HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after acquiring an additional 50 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded up $1.54 during trading on Tuesday, reaching $347.09. 241,945 shares of the stock were exchanged, compared to its average volume of 1,342,530. The firm has a market cap of $85.45 billion, a PE ratio of 15.76, a PEG ratio of 1.10 and a beta of 1.68. The stock has a 50-day moving average price of $325.24 and a 200-day moving average price of $340.60. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14.

Remove Ads

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the firm earned $5.90 earnings per share. Research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare's dividend payout ratio is presently 13.11%.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.30% of the stock is owned by insiders.

Analysts Set New Price Targets

Several brokerages have commented on HCA. Bank of America dropped their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a report on Monday, January 27th. Morgan Stanley lowered their target price on HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a report on Tuesday, December 17th. Barclays reduced their price objective on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research report on Monday, January 27th. Royal Bank of Canada reduced their price target on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research report on Monday, January 27th. Finally, Truist Financial cut their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.